RESEARCHER PROFILE (Filmed November 2023)
Dr Brendan Shannon
Head of Postgraduate Programs
Monash University
Melbourne, Australia
Dr Brendan Shannon is a registered paramedic and Head of Postgraduate Programs and Deputy Head of Department of Paramedicine at Monash University.
Transitioning from 12 years clinical work as a paramedic to academia, Dr. Brendan Shannon understands the importance of research and education in the field of healthcare. He became a paramedic, pursued higher education, and transitioned into academia while still maintaining a clinical workload.
Brendan has balanced clinical and academic experience throughout his career and his research is closely informed by paramedicine practice.
Brendan has a keen research interest in alternative care pathways, non-transport, referral services, paramedic practitioners and community paramedicine. His Doctoral research focused on investigating the experiences of health services when implementing alternative care pathways.
These pathways are designed to deliver care in community settings for populations that are traditionally underserved. The programs examined were found to effectively address complex patients’ needs in community settings.
Dr. Shannon is driven to help people’s lives be better, particularly those who don’t have the privileges as others. His focus is on treating underserved communities with chronic diseases and complex social conditions, who frequently use healthcare services, through community paramedicine programs, as well as patients who frequently utilise healthcare services like the emergency department.
“The intersection of chronic disease and complex social conditions presents a unique challenge in healthcare. Researching programs to increase access to care for underserved patients within the community is a big umbrella term with lots of avenues to explore”, says Dr Shannon.
Apart from research, having a purpose to help others and teaching, Dr Shannon has a passion for restoring old cars nurtured from family influences. He also takes part in amateur martial arts, in particular Brazilian jiu-jitsu.
-
Superslayer taking on antibiotic-resistant bacteria
Dr Katharina Richter is a visionary leader in MedTech, acclaimed for innovation and gender diversity. With over 40 awards to her name, including MIT Innovator Under 35 Asia-Pacific, and Prime Minister’s Prize for New Innovator finalist, she has shattered barriers as an entrepreneur, scientist, and ‘superbug slayer.’ Katharina’s groundbreaking work in combating antibiotic-resistant bacteria has resulted in 6 innovative treatments, 3 of which are patented, offering hope against deadly infections.
-
Muscle Cell Communication and Repair
Dr. William Roman is a Group Leader at the Australian Regenerative Medicine Institute (ARMI) at Monash University. He obtained his PhD from Paris Descartes University and Freie University of Berlin, focusing on nuclear positioning during skeletal muscle development. Dr. Roman’s research journey has taken him across the globe, including postdoctoral work in Barcelona, tissue engineering in Lisbon, and a brief stint at Stanford University.
At ARMI, Dr. Roman leads innovative research on intercellular communication within muscle organs. His work involves growing human muscles on chips to understand how skeletal muscle cells interact with neurons and tendons. This research aims to develop better models for studying muscle diseases, drug screening, and even applications in cellular agriculture and biorobotics.
-
Antimicrobial technologies & drug delivery platforms
Dr Aaron Elbourne is an ARC DECRA Fellow, Jack Brockhoff ECR Fellow, and Associate Professor within the School of Science at STEM Hub. A leader in nanomaterials, soft matter science, and interface research, Aaron’s work addresses critical challenges in health and the environment.
With a strong focus on translational research, Aaron’s work bridges the gap between fundamental science and practical applications. His leadership in creating innovative technologies, fostering academic-industry partnerships, and empowering future researchers underscores his commitment to advancing science and creating a meaningful impact.
